TNSN99152A1 - Composition antioxydante et antiproliferative comportant un carnitine et un carotenoide - Google Patents

Composition antioxydante et antiproliferative comportant un carnitine et un carotenoide

Info

Publication number
TNSN99152A1
TNSN99152A1 TNTNSN99152A TNSN99152A TNSN99152A1 TN SN99152 A1 TNSN99152 A1 TN SN99152A1 TN TNSN99152 A TNTNSN99152 A TN TNSN99152A TN SN99152 A TNSN99152 A TN SN99152A TN SN99152 A1 TNSN99152 A1 TN SN99152A1
Authority
TN
Tunisia
Prior art keywords
carotenoid
carnitine
composition
antioxidant
dietetic
Prior art date
Application number
TNTNSN99152A
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of TNSN99152A1 publication Critical patent/TNSN99152A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNE COMPOSITION COMPRENANT COMME INGREDIENTS ACTIFS CARACTERISTIQUES LE PROPIONYL L-CARNITINE ET AU MOINS UN CAROTENOIDE SPECIFIQUEMENT LE LYCOPENE EXTRAIT A PARTIR DE TOMATES ET QUI EST DESTINES A LA PREVENTION ET/OU AU TRAITEMENT THERAPEUTIQUE DES DIFFERENTES ALTERATIONS ET ETATS PATHOLOGIQUES INDUITS PAR LA PRESENCE DE RADICAUX A L'ETAT LIBRE, ET PAR LE PHENOMENE DE LIPOPEROXYDATION. CETTE COMPOSITION PEUT AVOIR LA FORME D'UN SUPPLEMENT DIETETIQUE, D'UN SUPPORT DIETETIQUE OU D'UN MEDICAMENT EFFECTIF
TNTNSN99152A 1998-08-03 1999-07-30 Composition antioxydante et antiproliferative comportant un carnitine et un carotenoide TNSN99152A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (it) 1998-08-03 1998-08-03 Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide

Publications (1)

Publication Number Publication Date
TNSN99152A1 true TNSN99152A1 (fr) 2005-11-10

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99152A TNSN99152A1 (fr) 1998-08-03 1999-07-30 Composition antioxydante et antiproliferative comportant un carnitine et un carotenoide

Country Status (21)

Country Link
EP (1) EP1102584A2 (fr)
JP (1) JP2002522382A (fr)
KR (1) KR20010072146A (fr)
CN (1) CN1311674A (fr)
AR (1) AR021172A1 (fr)
AU (1) AU5064199A (fr)
BR (1) BR9912703A (fr)
CA (1) CA2338035A1 (fr)
EE (1) EE200100052A (fr)
HK (1) HK1039062A1 (fr)
HU (1) HUP0102807A2 (fr)
IL (1) IL140797A0 (fr)
IS (1) IS5816A (fr)
IT (1) IT1302125B1 (fr)
MA (1) MA26666A1 (fr)
NO (1) NO20010532L (fr)
PL (1) PL346161A1 (fr)
SK (1) SK1252001A3 (fr)
TN (1) TNSN99152A1 (fr)
TR (1) TR200100333T2 (fr)
WO (1) WO2000007581A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5448284B2 (ja) 2000-06-02 2014-03-19 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム エチレンジシステイン（ｅｃ）−薬物結合体
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
JP4334189B2 (ja) * 2002-07-30 2009-09-30 カゴメ株式会社 Ａｇｅ生成阻害剤
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
ES2320995T3 (es) 2003-04-14 2009-06-01 Nippon Soda Co., Ltd. Derivado de diamina, procedimiento de produccion y farmaco antioxidante.
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
JP2007519678A (ja) * 2004-01-28 2007-07-19 ネステク ソシエテ アノニム 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (fr) * 1989-06-02 1990-12-05 Abbott Laboratories Produit de nutrition parentéral
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
BR9912703A (pt) 2001-05-02
CA2338035A1 (fr) 2000-02-17
EP1102584A2 (fr) 2001-05-30
KR20010072146A (ko) 2001-07-31
SK1252001A3 (en) 2001-08-06
HK1039062A1 (zh) 2002-04-12
IS5816A (is) 2001-01-16
IT1302125B1 (it) 2000-07-31
AU5064199A (en) 2000-02-28
EE200100052A (et) 2002-06-17
ITRM980516A0 (it) 1998-08-03
AR021172A1 (es) 2002-07-03
IL140797A0 (en) 2002-02-10
ITRM980516A1 (it) 2000-02-03
HUP0102807A2 (hu) 2002-03-28
JP2002522382A (ja) 2002-07-23
NO20010532L (no) 2001-03-20
WO2000007581A2 (fr) 2000-02-17
PL346161A1 (en) 2002-01-28
CN1311674A (zh) 2001-09-05
TR200100333T2 (tr) 2001-07-23
NO20010532D0 (no) 2001-01-31
MA26666A1 (fr) 2004-12-20
WO2000007581A3 (fr) 2000-05-11

Similar Documents

Publication Publication Date Title
TNSN99163A1 (fr) COMPOSITION ANTIOXYDANTE COMPRENANT L'ACETYL-CARNITINE ET L'ACIDE α -LIPOIQUE QUI AMELIORE L'UTILISATION METABOLIQUE DU GLUCOSE
TNSN99152A1 (fr) Composition antioxydante et antiproliferative comportant un carnitine et un carotenoide
NO20012954L (no) Olje-i-vann-emulsjon omfattende et mikronisert biologisk aktivt middel og et passende emulgeringsmiddelsystem
CA2274596A1 (fr) Compositions et procedes servant a ameliorer le fonctionnement gastro-intestinal
GR3030153T3 (en) Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same
DE69815323D1 (de) Therapeutische nahrung für diabätiker
CA2223510A1 (fr) Intercepteurs catalytiques synthetiques de radicaux libres s'utilisant comme antioxydants dans la prevention et le traitement de maladies
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
BG103646A (en) Arylsulphonamides, their analogues and application for the treatment of neurodegenerative diseases
EP1163905A4 (fr) Preparations pour la peau a usage externe
WO1999066914A3 (fr) Composition neuroprotectrice utilisee dans la prevention et/ou le traitement de modifications du systeme nerveux et du comportement induites par des etats anxieux ou depressifs
CA2334919A1 (fr) Composition comprenant une carnitine et du glutathion, servant a accroitre l'absorption du glutathion et a lui conferer une action synergique
CO5221082A1 (es) Llenantes que contienen humedad no basada en emulsion, para productos de masa
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
CA2253130A1 (fr) Medicament pour traiter l'obesite et ameliorer le metabolisme lipidique
CA2258503A1 (fr) Compositions de lectine et utilisation de ces compositions
BR0011447A (pt) Composição compreendendo esfingomielinase alcalina para aplicação como uma preparação dietética, suplemento alimentar ou produto farmacêutico
TNSN99138A1 (fr) Une composition antioxydante, cytostatique et a support energetique qui ameliore l'utilisation metabolique du glucose
WO1998032428A3 (fr) Compositions a base de choline et utilisation de la choline pour traiter les chocs endotoxiques
TNSN99212A1 (fr) Composition antioxydante et preventive contre les anomalies thrombotiques et atherosclerotiques, comportant un carnitine et un flavonoide
CA2291811A1 (fr) Aliment contenant du zinc et de l'acide linoleique
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
ATE214935T1 (de) Robinia pseudoacacia lektin und seine verwendungen
ATE239504T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von störungen aufgrund von abnormalen fettstoffmetabolismus, enthaltend l-carnitin und chitosan
CA2285012A1 (fr) Medicament pour application externe et utilisation d'une emulsion huile dans eau pour ledit medicament